Suchergebnisse - "CLIA"

PubPharm (345)

51

Evaluation of qualitative and semi-quantitative cut offs for rapid diagnostic lateral flow test in relation to serology for the detection of SARS-CoV-2 antibodies: findings of a prospective study

enthalten in: BMC infectious diseases | 2022

von Peghin, M. | Bontempo, G. | De Martino, M. | +10

52

Evaluation of qualitative and semi-quantitative cut offs for rapid diagnostic lateral flow test in relation to serology for the detection of SARS-CoV-2 antibodies: findings of a prospective study

enthalten in: BMC infectious diseases | 2022

von Peghin, M. | Bontempo, G. | De Martino, M. | +10

53

Clinical Laboratory Utility of a Humanized Antibody in Commercially Available Enzyme Immunoassays for Coccidioidomycosis

enthalten in: Microbiology spectrum | 2022

von Grill, F. | Jugler, C. | Kaleta, E. | +4

54

Cepheid Xpert Xpress Flu/RSV evaluation performed by minimally trained non-laboratory operators in a CLIA-waived environment

enthalten in: Diagnostic microbiology and infectious disease | 2022

von Shihabuddin, B. | Faron, M. | Relich, R. | +16

55

Use of Uncertainty of Measurement for Traceability of Test Results and Setting up of own Quality Goal for Methods having Lower Stability- A Tertiary Care Hospital study

enthalten in: Indian journal of clinical biochemistry : IJCB | 2022

von Chawla, R. | Subberwal, M. | Singhal, A.

56

A How to Guide : Clinical Population Test Development and Authorization of MALDI-ToF Mass Spectrometry-Based Screening Tests for Viral Infections

enthalten in: Viruses | 2022

von Iles, R. | Iles, J. | Zmuidinaite, R. | +1

57

Regulation of Molecular Diagnostics

enthalten in: Annual review of genomics and human genetics | 2022

von Javitt, G. | Vollebregt, E.

58

Validation Study of a New Random-Access Chemiluminescence Immunoassay Analyzer i-TRACK10® to Monitor Infliximab and Adalimumab Serum trough Levels and Anti-Drug Antibodies

enthalten in: International journal of molecular sciences | 2022

von Berger, A. | Gleizes, A. | Waeckel, L. | +5

59

Validation of a Novel Fluorescent Lateral Flow Assay for Rapid Qualitative and Quantitative Assessment of Total Anti-SARS-CoV-2 S-RBD Binding Antibody Units (BAU) from Plasma or Fingerstick Whole-Blood of COVID-19 Vaccinees

enthalten in: Vaccines | 2022

von Younes, N. | Al-Sadeq, D. | Shurrab, F. | +18

60

Commercialized kits to assess T-cell responses against SARS-CoV-2 S peptides. A pilot study in health care workers

enthalten in: Medicina clinica (English ed.) | 2022

von Martínez-Gallo, M. | Esperalba, J. | Pujol-Borrell, R. | +8